VIJAYA Vijaya Diagnostic Centre Q1 FY26 results (Apr–Jun 2025) and concall
Vijaya Diagnostic Centre delivered a strong Q1 FY26 with 20.4% revenue growth, driven by robust test volumes and a favorable mix. The company maintained healthy margins despite commissioning new hubs, attributing success to brand strength and operating leverage. Management reiterated its B2C focus and organic expansion plans, while also actively seeking inorganic growth opportunities.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 183 | 169 | 173 | 188 |
| EBITDA | 76 | 67 | 69 | 74 |
| Net profit | 42 | 35 | 35 | 39 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
